Technology Transfers To Least-Developed Countries Often Not An Option - IFPMA Report
This article was originally published in PharmAsia News
Executive SummaryHONG KONG - The transfer of technology developed by high-end research-based pharmaceutical companies to operations in developing countries is increasingly common, but rarely simple
You may also be interested in...
PEPFAR-supported countries are not ready to take over their AIDS programs as projected, in part because of the financial crisis.